Ishihara Sangyo Kaisha (4028) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
7 Aug, 2026Executive summary
Net sales for the three months ended June 30, 2026, declined 7.7% year-over-year to ¥39,289 million, with operating profit down 57.6% to ¥2,206 million and profit attributable to owners of parent falling 78.6% to ¥1,013 million.
Comprehensive income decreased 52.5% year-over-year to ¥2,048 million.
Financial highlights
Gross profit for Q1 FY2027 was ¥11,388 million, down from ¥12,316 million in the prior year.
Ordinary profit dropped 33.1% year-over-year to ¥4,142 million.
Basic earnings per share for the quarter was ¥26.49, compared to ¥123.82 in the previous year.
Total assets as of June 30, 2026, were ¥237,014 million, with net assets at ¥127,740 million.
Outlook and guidance
Full-year FY2027 net sales are forecast at ¥150,000 million, down 3.2% year-over-year.
Operating profit is projected to decrease 25.6% to ¥14,200 million, and profit attributable to owners of parent is expected to fall 38.8% to ¥8,150 million.
Basic earnings per share for the full year is forecast at ¥213.09.
Management notes risks from global economic conditions, competition, and foreign currency fluctuations.
Latest events from Ishihara Sangyo Kaisha
- Net sales rose 10.4% but net income fell 80.6% due to forex losses and higher costs.4028
Q2 20257 Aug 2026 - Profits and forecasts surged on strong overseas sales, cost controls, and a favorable outlook.4028
Q2 20267 Aug 2026 - FY2025 is forecasted for higher profit and a ¥100 dividend as inorganic chemicals recover.4028
Q4 20257 Aug 2026 - Profits surged in FY2025, but FY2026/FY2027 is forecast to decline amid higher R&D and normalized demand.4028
Q4 20265 Jun 2026 - Strong profit growth and positive outlook, driven by Organic Chemicals segment.4028
Q3 202613 Feb 2026 - Q1 FY2025 profit dropped over 40% year-over-year despite stable sales; outlook revised down.4028
Q1 202520 Nov 2025 - Sales and operating income rose, but net income fell; dividend forecast increased.4028
Q3 202520 Nov 2025 - Operating profit surged 191% year-over-year, with strong sales and raised full-year guidance.4028
Q1 202620 Nov 2025